ID   KRAF1_CAEEL             Reviewed;         813 AA.
AC   Q07292; Q6RT23; Q8MXT8; Q9N4E3;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   11-JUL-2002, sequence version 2.
DT   07-APR-2021, entry version 182.
DE   RecName: Full=Raf homolog serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Abnormal cell lineage protein 45;
GN   Name=lin-45; Synonyms=raf-1; ORFNames=Y73B6A.5;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), AND FUNCTION.
RC   STRAIN=Bristol N2;
RX   PubMed=8483497; DOI=10.1038/363133a0;
RA   Han M., Golden A., Han Y., Sternberg P.W.;
RT   "C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval
RT   differentiation.";
RL   Nature 363:133-140(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C).
RX   PubMed=15105376; DOI=10.1101/gad.1188404;
RA   Lee M.-H., Schedl T.;
RT   "Translation repression by GLD-1 protects its mRNA targets from nonsense-
RT   mediated mRNA decay in C. elegans.";
RL   Genes Dev. 18:1047-1059(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING.
RC   STRAIN=Bristol N2;
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [4]
RP   FUNCTION, AND MUTAGENESIS OF PRO-92; ARG-108; ARG-118; SER-645; ILE-726 AND
RP   SER-754.
RX   PubMed=11861555;
RA   Hsu V., Zobel C.L., Lambie E.J., Schedl T., Kornfeld K.;
RT   "Caenorhabditis elegans lin-45 raf is essential for larval viability,
RT   fertility and the induction of vulval cell fates.";
RL   Genetics 160:481-492(2002).
RN   [5]
RP   FUNCTION.
RX   PubMed=15268855; DOI=10.1016/j.cub.2004.07.022;
RA   Nicholas H.R., Hodgkin J.;
RT   "The ERK MAP kinase cascade mediates tail swelling and a protective
RT   response to rectal infection in C. elegans.";
RL   Curr. Biol. 14:1256-1261(2004).
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF SER-312 AND SER-453.
RX   PubMed=14724126; DOI=10.1242/dev.00987;
RA   Kao G., Tuck S., Baillie D., Sundaram M.V.;
RT   "C. elegans SUR-6/PR55 cooperates with LET-92/protein phosphatase 2A and
RT   promotes Raf activity independently of inhibitory Akt phosphorylation
RT   sites.";
RL   Development 131:755-765(2004).
RN   [7]
RP   INTERACTION WITH CDF-1.
RX   PubMed=15096503; DOI=10.1074/jbc.m401210200;
RA   Jirakulaporn T., Muslin A.J.;
RT   "Cation diffusion facilitator proteins modulate Raf-1 activity.";
RL   J. Biol. Chem. 279:27807-27815(2004).
RN   [8]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19826475; DOI=10.1371/journal.pone.0007450;
RA   Schouest K.R., Kurasawa Y., Furuta T., Hisamoto N., Matsumoto K.,
RA   Schumacher J.M.;
RT   "The germinal center kinase GCK-1 is a negative regulator of MAP kinase
RT   activation and apoptosis in the C. elegans germline.";
RL   PLoS ONE 4:E7450-E7450(2009).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=20624915; DOI=10.1074/jbc.m110.146274;
RA   Okuyama T., Inoue H., Ookuma S., Satoh T., Kano K., Honjoh S., Hisamoto N.,
RA   Matsumoto K., Nishida E.;
RT   "The ERK-MAPK pathway regulates longevity through SKN-1 and insulin-like
RT   signaling in Caenorhabditis elegans.";
RL   J. Biol. Chem. 285:30274-30281(2010).
CC   -!- FUNCTION: Protein kinase that participates in the induction of vulva
CC       and has roles in fertility and viability. Acts downstream of the Ras
CC       protein let-60 (PubMed:8483497, PubMed:11861555, PubMed:14724126).
CC       Required for progression of developing oocytes through the pachytene
CC       stage (PubMed:19826475). Plays a role in responses to M.nematophilum-
CC       mediated bacterial infection by promoting tail swelling and preventing
CC       constipation (PubMed:15268855). Positively regulates lifespan upstream
CC       of mek-2 and mpk-1 (PubMed:20624915). {ECO:0000269|PubMed:11861555,
CC       ECO:0000269|PubMed:14724126, ECO:0000269|PubMed:15268855,
CC       ECO:0000269|PubMed:19826475, ECO:0000269|PubMed:8483497}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Interacts with cdf-1 in a zinc-dependent manner which promotes
CC       its activity. {ECO:0000269|PubMed:15096503}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=a;
CC         IsoId=Q07292-1; Sequence=Displayed;
CC       Name=b;
CC         IsoId=Q07292-2; Sequence=VSP_020620, VSP_020622, VSP_020623;
CC       Name=c;
CC         IsoId=Q07292-3; Sequence=VSP_020621;
CC   -!- DISRUPTION PHENOTYPE: RNAi-mediated knockdown causes a defect in
CC       pachytene progression resulting in a proximal gonad devoid of nuclei.
CC       The phenotype is more severe in gck-1 (km15) mutant (PubMed:19826475).
CC       RNAi-mediated knockdown in adults decreases lifespan (PubMed:20624915).
CC       {ECO:0000269|PubMed:19826475, ECO:0000269|PubMed:20624915}.
CC   -!- MISCELLANEOUS: Gld-1 binds to the 3'-UTR of lin-45 mRNA and is able to
CC       protect nonsense-containing lin-45 mRNA from nonsense mediated decay
CC       (NMD).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. RAF subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L15347; AAA28142.1; -; mRNA.
DR   EMBL; AY455928; AAR26307.1; -; mRNA.
DR   EMBL; AY493413; AAR86712.1; -; mRNA.
DR   EMBL; AY493414; AAR86713.1; -; mRNA.
DR   EMBL; FO080249; CCD62343.1; -; Genomic_DNA.
DR   EMBL; FO080249; CCD62344.1; -; Genomic_DNA.
DR   PIR; S33261; S33261.
DR   RefSeq; NP_001293844.1; NM_001306915.1.
DR   RefSeq; NP_741430.3; NM_171367.5. [Q07292-1]
DR   RefSeq; NP_741431.2; NM_171368.2.
DR   SMR; Q07292; -.
DR   BioGRID; 42556; 21.
DR   IntAct; Q07292; 4.
DR   STRING; 6239.Y73B6A.5a.1; -.
DR   iPTMnet; Q07292; -.
DR   EPD; Q07292; -.
DR   PaxDb; Q07292; -.
DR   PeptideAtlas; Q07292; -.
DR   EnsemblMetazoa; Y73B6A.5a.1; Y73B6A.5a.1; WBGene00003030. [Q07292-1]
DR   EnsemblMetazoa; Y73B6A.5b.1; Y73B6A.5b.1; WBGene00003030.
DR   GeneID; 177436; -.
DR   UCSC; Y73B6A.5a.1; c. elegans. [Q07292-1]
DR   CTD; 177436; -.
DR   WormBase; Y73B6A.5a; CE25585; WBGene00003030; lin-45. [Q07292-1]
DR   WormBase; Y73B6A.5b; CE49395; WBGene00003030; lin-45.
DR   eggNOG; KOG0193; Eukaryota.
DR   GeneTree; ENSGT00940000173714; -.
DR   InParanoid; Q07292; -.
DR   OrthoDB; 243095at2759; -.
DR   PhylomeDB; Q07292; -.
DR   Reactome; R-CEL-2672351; Stimuli-sensing channels.
DR   Reactome; R-CEL-392517; Rap1 signalling.
DR   Reactome; R-CEL-430116; GP1b-IX-V activation signalling.
DR   Reactome; R-CEL-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-CEL-5674135; MAP2K and MAPK activation.
DR   Reactome; R-CEL-5674499; Negative feedback regulation of MAPK pathway.
DR   Reactome; R-CEL-5675221; Negative regulation of MAPK pathway.
DR   SignaLink; Q07292; -.
DR   PRO; PR:Q07292; -.
DR   Proteomes; UP000001940; Chromosome IV.
DR   Bgee; WBGene00003030; Expressed in material anatomical entity and 5 other tissues.
DR   ExpressionAtlas; Q07292; baseline and differential.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0031267; F:small GTPase binding; IPI:WormBase.
DR   GO; GO:0001708; P:cell fate specification; IMP:WormBase.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; IMP:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0002119; P:nematode larval development; IMP:WormBase.
DR   GO; GO:0048477; P:oogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007265; P:Ras protein signal transduction; IGI:WormBase.
DR   GO; GO:0000003; P:reproduction; IMP:WormBase.
DR   GO; GO:0040025; P:vulval development; IMP:UniProtKB.
DR   CDD; cd00029; C1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR003116; RBD_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF02196; RBD; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00455; RBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50898; RBD; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Developmental protein; Differentiation;
KW   Kinase; Meiosis; Metal-binding; Nucleotide-binding; Oogenesis;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..813
FT                   /note="Raf homolog serine/threonine-protein kinase"
FT                   /id="PRO_0000086193"
FT   DOMAIN          85..161
FT                   /note="RBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00262"
FT   DOMAIN          481..748
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ZN_FING         170..217
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   NP_BIND         487..495
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   ACT_SITE        602
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   METAL           184
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           187
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           198
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           201
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   METAL           206
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           209
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000250"
FT   METAL           217
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000250"
FT   BINDING         507
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   VAR_SEQ         1..44
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000303|PubMed:15105376"
FT                   /id="VSP_020621"
FT   VAR_SEQ         1
FT                   /note="M -> MSAMAVLYSVCHFHGGWNRRKSAPKSPVTSSQTPSSSSTRRRM (in
FT                   isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020620"
FT   VAR_SEQ         569..572
FT                   /note="EPRV -> GDLN (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020622"
FT   VAR_SEQ         573..813
FT                   /note="Missing (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020623"
FT   MUTAGEN         92
FT                   /note="P->S: In n2018; 76% larval lethal, 24% abnormal
FT                   vulval development."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   MUTAGEN         108
FT                   /note="R->W: In n1925; no effect."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   MUTAGEN         118
FT                   /note="R->W: In n2506; 86% larval lethal, 93% abnormal
FT                   vulval development."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   MUTAGEN         312
FT                   /note="S->A: Probably abolishes phosphorylation. Multivulva
FT                   formation. Multivulva formation; when associated with A-
FT                   453."
FT                   /evidence="ECO:0000269|PubMed:14724126"
FT   MUTAGEN         453
FT                   /note="S->A: Probably abolishes phosphorylation. Multivulva
FT                   formation; when associated with A-312."
FT                   /evidence="ECO:0000269|PubMed:14724126"
FT   MUTAGEN         645
FT                   /note="S->N: In oz178 and oz201; 55% larval lethal, 100%
FT                   abnormal vulval development."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   MUTAGEN         726
FT                   /note="I->F: In n1924; 5% larval lethal, no effect on
FT                   vulval development."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   MUTAGEN         754
FT                   /note="S->F: In n2520 and n2523; no effect."
FT                   /evidence="ECO:0000269|PubMed:11861555"
FT   CONFLICT        801
FT                   /note="A -> R (in Ref. 1; AAA28142)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   813 AA;  90407 MW;  6376E968D11A9E49 CRC64;
     MSRINFKKSS ASTTPTSPHC PSPRLISLPR CASSSIDRKD QASPMASPST PLYPKHSDSL
     HSLSGHHSAG GAGTSDKEPP KFKYKMIMVH LPFDQHSRVE VRPGETARDA ISKLLKKRNI
     TPQLCHVNAS SDPKQESIEL SLTMEEIASR LPGNELWVHS EYLNTVSSIK HAIVRRTFIP
     PKSCDVCNNP IWMMGFRCEF CQFKFHQRCS SFAPLYCDLL QSVPKNEDLV KELFGIASQV
     EGPDRSVAEI VLANLAPTSG QSPAATPDSS HPDLTSIKRT GGVKRHPMAV SPQNETSQLS
     PSGPYPRDRS SSAPNINAIN DEATVQHNQR ILDALEAQRL EEESRDKTGS LLSTQARHRP
     HFQSGHILSG ARMNRLHPLV DCTPLGSNSP SSTCSSPPGG LIGQPTLGQS PNVSGSTTSS
     LVAAHLHTLP LTPPQSAPPQ KISPGFFRNR SRSPGERLDA QRPRPPQKPH HEDWEILPNE
     FIIQYKVGSG SFGTVYRGEF FGTVAIKKLN VVDPTPSQMA AFKNEVAVLK KTRHLNVLLF
     MGWVREPEIA IITQWCEGSS LYRHIHVQEP RVEFEMGAII DILKQVSLGM NYLHSKNIIH
     RDLKTNNIFL MDDMSTVKIG DFGLATVKTK WTVNGGQQQQ QPTGSILWMA PEVIRMQDDN
     PYTPQSDVYS FGICMYEILS SHLPYSNINN RDQILFMVGR GYLRPDRSKI RHDTPKSMLK
     LYDNCIMFDR NERPVFGEVL ERLRDIILPK LTRSQSAPNV LHLDSQYSVM DAVMRSQMLS
     WSYIPPATAK TPQSAAAAAA ANKKAYYNVY GLI
//
